Literature DB >> 31508187

THE MULTIFARIOUS CUSHING'S - LESSONS FROM A CASE SERIES.

I Ilie1, V Ciubotaru2, A Tulin3, D Hortopan1, A Caragheorgheopol1, M Purice1, C Neamtu4, V I Elian5, A Banica1, L Oprea1, M Musat1,6.   

Abstract

Endogenous Cushing's syndrome is rare, with an incidence of 0.7-2.4 per a million people a year. Clinical presentation of Cushing syndrome can be pleomorphic, and establishing diagnosis can be difficult. Early recognition and rapid control of hypercortisolaemia are necessary to decrease morbidity and mortality in these patients. We report a series of 6 endogenous Cushing's syndromes of different etiologies (4 Cushing's disease and 2 adrenal Cushing's syndrome) assessed in our endocrine department over a decade (2009-2019). In order to highlight the diversity of clinical forms, diagnostic tools and specific management of this condition we labelled each case suggestively: the typical Cushing's disease, the Pseudo Cushing's, the elusive Cushing's disease, the mild autonomous cortisol hypersecretion, Cushing's syndrome in pregnancy and Cushing's disease with thromboembolism. We discussed their particularities which were revelatory for the diagnosis, such as dermatologic, cardiovascular, musculoskeletal, neuropsychiatric, or reproductive signs, reviewing literature for each manifestation. We also discuss the commonalities and differences in laboratory and imagistic findings. Therapeutic approach can also differ with respect to the particular condition of each patient and the multiple choices of therapy will be reviewed.

Entities:  

Keywords:  Cushing’s disease.; Cushing’s syndrome

Year:  2019        PMID: 31508187      PMCID: PMC6711653          DOI: 10.4183/aeb.2019.261

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  26 in total

1.  Psychiatric phenomenology in Cushing's disease.

Authors:  P T Loosen; B Chambliss; C R DeBold; R Shelton; D N Orth
Journal:  Pharmacopsychiatry       Date:  1992-07       Impact factor: 5.788

Review 2.  Cushing's syndrome.

Authors:  John Newell-Price; Xavier Bertagna; Ashley B Grossman; Lynnette K Nieman
Journal:  Lancet       Date:  2006-05-13       Impact factor: 79.321

3.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

4.  Incidence and late prognosis of cushing's syndrome: a population-based study.

Authors:  J Lindholm; S Juul; J O Jørgensen; J Astrup; P Bjerre; U Feldt-Rasmussen; C Hagen; J Jørgensen; M Kosteljanetz; L Kristensen; P Laurberg; K Schmidt; J Weeke
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

5.  Gonadotropin pulsatility in Cushing's syndrome compared with polycystic ovary syndrome.

Authors:  Zorana Penezić; Milos Zarković; Svetlana Vujović; Jasmina Cirić; Biljana Beleslin; Miomira Ivović; Ana Pokrajac; Milka Drezgić
Journal:  Gynecol Endocrinol       Date:  2005-03       Impact factor: 2.260

Review 6.  Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.

Authors:  V Hána; M Dokoupilová; J Marek; R Plavka
Journal:  Clin Endocrinol (Oxf)       Date:  2001-02       Impact factor: 3.478

Review 7.  The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment.

Authors:  John R Lindsay; Lynnette K Nieman
Journal:  Endocr Rev       Date:  2005-04-12       Impact factor: 19.871

8.  Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

Authors:  Ramaswamy Govindan; Nathan Page; Daniel Morgensztern; William Read; Ryan Tierney; Anna Vlahiotis; Edward L Spitznagel; Jay Piccirillo
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

9.  Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.

Authors:  Blerina Kola; Mirjam Christ-Crain; Francesca Lolli; Giorgio Arnaldi; Gilberta Giacchetti; Marco Boscaro; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

Review 10.  Hypercoagulable state in Cushing's syndrome: a systematic review.

Authors:  Bregje Van Zaane; Erfan Nur; Alessandro Squizzato; Olaf M Dekkers; Marcel Th B Twickler; Eric Fliers; Victor E A Gerdes; Harry R Büller; Dees P M Brandjes
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

View more
  2 in total

1.  Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.

Authors:  A Scutelnicu; A M Panaitescu; A M Ciobanu; N Gica; R Botezatu; G Peltecu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

2.  Effectiveness of Medical Treatment of Cushing's Disease: A Systematic Review and Meta-Analysis.

Authors:  Julia Simões Corrêa Galendi; Afonso Nogueira Simões Correa Neto; Michelle Demetres; Cesar Luiz Boguszewski; Vania Dos Santos Nunes Nogueira
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-17       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.